Skip to Main Content

Paper Details

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.
J Natl Cancer Inst
33
2021
ATM, ATM LoF, ATM Mutations, ATM mutation, Cancer, TP53, TP53 wild, TP53 wild-, TP53 wild-type tumors, TP53-mutant tumors, advanced cancer, ataxia-telangiectasia, cancer, cancers, hereditary syndrome, irradiated, pan-cancer, patients, radio, tumor, tumor phenotype, tumors
Author NameAffiliation
Zhigang ZhangMemorial Sloan Kettering Cancer Center
Luc G T MorrisMemorial Sloan Kettering Cancer Center
Howard I ScherMemorial Sloan Kettering Cancer Center
Jonine L BernsteinMemorial Sloan Kettering Cancer Center
Britta WeigeltMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Nancy Y LeeMemorial Sloan Kettering Cancer Center
Simon N PowellMemorial Sloan Kettering Cancer Center
Simon N PowellSloan Kettering Institute
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Nadeem RiazMemorial Sloan Kettering Cancer Center
Nadeem RiazMemorial Sloan Kettering Cancer Center
  • 1 - 18

Datasets

Release 1.2